Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Learn about retirement plans that might be better than a 401k. Enhance your retirement strategy with informed choices.
27,827 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
This article explores how spacex secret autonomous driving might create a surprising investment edge. Learn the mecha...
Unlock the signals behind American Water Works earnings calls. Learn how to read the transcript, spot growth drivers,...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
NVIDIA continues to outpace AMD in data-center AI hardware even as a Kyber rack delay looms, reinforcing Nvidia’s moa...
Travel finally bounced back, and hotel owners like Host Hotels faced a new set of challenges and opportunities. This ...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
Paradex has signaled an imminent native token launch with its $DIME token generation event. The move aims to deepen l...
Circle stock jumped february as investors weighed an earnings beat against a choppy crypto backdrop. This article unp...
Tariff-Related Lawsuits Could Hurt Costco Stock Now examines how legal challenges tied to tariffs can affect a retail...